ObjectiveApproximately 10% of pregnant women suffer from pregnancy-associated depression. Fluoxetine, as a selective serotonin reuptake inhibitor, is being employed as a therapy for depressive disorders. The present study aimed to determine the effects of fluoxetine on neonatal lung development.MethodsThirty pregnant Wistar rats (weighing 200–250 g) were treated daily with 7 mg/kg fluoxetine from gestation day 0 to gestation day 21, via gavage. The control group received a similar volume of distilled water only. Following delivery, the newborns and their lungs were immediately weighed in both of the groups. The right lung was fixed for histological assessments while the left lung was used for evaluation of the expression of SPC and HoxB5 by the real-time polymerase chain reaction method.ResultsResults have indicated that even though the body weight and the number of neonatal rats in both groups were the same, the lung weight of neonates exposed to fluoxetine was significantly different compared to the control group (P<0.05). Expression of both genes was increased, nonetheless, only elevation of HoxB5 was significant (P<0.05). Histological studies demonstrated that lung tissue in the fluoxetine treatment group morphologically appears to be similar to the pseudoglandular phase, whereas the control group lungs experienced more development.ConclusionAccording to the upregulated expression of HoxB5 concerning histological findings, results of the present study showed that fluoxetine can influence lung growth and may in turn lead to delay in lung development. So establishment of studies to identify the effects of antidepressant drugs during pregnancy is deserved.

Fluoxetine is one of the most commonly used antidepressants. Fluoxetine could prevent the mesenchymal stem cell differentiation in lung fetus of rat. Moreover, the mesenchymal stem cells are also present in adult tissues. Therefore, in the current study, we aimed to investigate the effects of fluoxetine (FLX) on both proliferation and adipogenic/osteogenic differentiation of human adipose‐derived stem cells (ADSCs). After culturing of human ADSCs, these cells were treated with two concentrations of FLX (10 and 20 μm). Then, cells were differentiated by adding osteogenic and adipogenic media. The effect of FLX on human ADSCs proliferation was evaluated by MTT assay. Fluoxetine role on adipogenic and osteogenic differentiation of human ADSCs was analyzed by oil red and alizarin red staining and RT‐PCR reaction. According to MTT assay, FLX showed a time‐ and concentration‐dependent proliferation response and eventually decreased human ADSCs proliferation. RT‐PCR analysis indicated that FLX significantly diminished the expression of osteogenesis‐related genes such as RUNX2 and alkaline phosphatase (ALP). Data also revealed a significant reduction in the expression of peroxisome proliferator‐activated receptor γ (PPARγ) and fatty acid‐binding protein (FABP) (specific genes of adipogenic lineage). In addition, FLX decreased mineralized matrix and the amount of lipid droplets in human ADSCs by staining methods. Our observation demonstrated that the effects of FLX may be time‐dependent. This drug possesses an increasing phase in proliferation and survival of human ADSCs (first 24 h) following a decreasing phase (after 48 h). Moreover, FLX could attenuate both osteogenic and adipogenic differentiation of human ADSCs.

No abstract

Background: Tobacco use in various forms, including hookah, has increased in recent years, especially among young people, who are the group of reproductive age. In the present study, the effect of nicotine on fibronectin expression as a component of basement membrane and extracellular matrix was evaluated in the kidney tissue of neonates whose mothers were exposed to cigarette smoke during pregnancy and lactation period. Methods: Fibronectin expression on days 1, 7, 14, and 21 after delivery was evaluated in the kidneys of Balb/C mice neonates whose mothers were exposed to cigarette smoking during pregnancy and lactation periods. Immunohistochemical and real-time PCR evaluations were performed, and a comparison was made with the control groups. In the experimental groups, nicotine dissolved in saline was injected subcutaneously at a dose of 2 mg/kg daily until the desired day. Results: Our results demonstrated that the expression level of fibronectin increased in nicotine-administrated newborns compared to the healthy controls on days 1 (P = 0.043) and 7 (P = 0.008). The intensity of color reaction on days 1 and 7 was significantly higher in the main kidney structures, including glomeruli and proximal and distal convoluted tubules, in the experimental group than in the control group. The maximum fibronectin expression level was observed on day 7 in the experimental group in comparison with the control group. Conclusions: Nicotine may decrease glomerular filtration rate by increasing fibronectin expression in the basement membrane and extracellular matrix, thereby justifying renal failure in infants exposed to nicotine during embryonic and lactation periods.